216 related articles for article (PubMed ID: 20953904)
1. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.
Fearnley EJ; Marquart L; Spurdle AB; Weinstein P; Webb PM;
Cancer Causes Control; 2010 Dec; 21(12):2303-8. PubMed ID: 20953904
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome and endometrial cancer.
Navaratnarajah R; Pillay OC; Hardiman P
Semin Reprod Med; 2008 Jan; 26(1):62-71. PubMed ID: 18181084
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of coffee consumption and the risk of endometrial endometrioid adenocarcinoma.
Koizumi T; Nakaya N; Okamura C; Sato Y; Shimazu T; Nagase S; Niikura H; Kuriyama S; Tase T; Ito K; Tsubono Y; Okamura K; Yaegashi N; Tsuji I
Eur J Cancer Prev; 2008 Aug; 17(4):358-63. PubMed ID: 18562962
[TBL] [Abstract][Full Text] [Related]
4. The association between polycystic ovaries and endometrial cancer.
Pillay OC; Te Fong LF; Crow JC; Benjamin E; Mould T; Atiomo W; Menon PA; Leonard AJ; Hardiman P
Hum Reprod; 2006 Apr; 21(4):924-9. PubMed ID: 16361289
[TBL] [Abstract][Full Text] [Related]
5. Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.
Sturgeon SR; Sherman ME; Kurman RJ; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Brinton LA
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):231-5. PubMed ID: 9521439
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism.
Holm NS; Glintborg D; Andersen MS; Schledermann D; Ravn P
Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1173-6. PubMed ID: 22583042
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome and the postmenopausal woman.
Ireland K; Child T
J Br Menopause Soc; 2006 Dec; 12(4):143-8. PubMed ID: 17178014
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
[TBL] [Abstract][Full Text] [Related]
9. Endometrial adenocarcinoma and polycystic ovary syndrome: risk factors, management, and prognosis.
Elliott JL; Hosford SL; Demopoulos RI; Perloe M; Sills ES
South Med J; 2001 May; 94(5):529-31. PubMed ID: 11372809
[TBL] [Abstract][Full Text] [Related]
10. Diabetes risk score in the diagnostic categories of polycystic ovary syndrome.
Moran LJ; Strauss BJ; Teede HJ
Fertil Steril; 2011 Apr; 95(5):1742-8. PubMed ID: 21316662
[TBL] [Abstract][Full Text] [Related]
11. Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study.
Gottschau M; Kjaer SK; Jensen A; Munk C; Mellemkjaer L
Gynecol Oncol; 2015 Jan; 136(1):99-103. PubMed ID: 25451694
[TBL] [Abstract][Full Text] [Related]
12. Variants in DENND1A and LHCGR are associated with endometrioid adenocarcinoma.
Wang Z; Li T; Zhang W; You L; Zhao Y; Xia M; Zhao H; Chen ZJ
Gynecol Oncol; 2012 Nov; 127(2):403-5. PubMed ID: 22902918
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS).
Bhattacharya SM; Jha A
Fertil Steril; 2010 Jun; 94(1):357-9. PubMed ID: 19896652
[TBL] [Abstract][Full Text] [Related]
14. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in polycystic ovary syndrome.
Carmina E
Minerva Ginecol; 2006 Apr; 58(2):109-14. PubMed ID: 16582867
[TBL] [Abstract][Full Text] [Related]
16. Family history of cancer and the risk of endometrial cancer.
Lucenteforte E; Talamini R; Montella M; Dal Maso L; Pelucchi C; Franceschi S; La Vecchia C; Negri E
Eur J Cancer Prev; 2009 Apr; 18(2):95-9. PubMed ID: 19337055
[TBL] [Abstract][Full Text] [Related]
17. Oncological repercussions of polycystic ovary syndrome.
de França Neto AH; Rogatto S; Do Amorim MM; Tamanaha S; Aoki T; Aldrighi JM
Gynecol Endocrinol; 2010 Oct; 26(10):708-11. PubMed ID: 20528205
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F
Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
[TBL] [Abstract][Full Text] [Related]
19. Use of talcum powder and endometrial cancer risk.
Neill AS; Nagle CM; Spurdle AB; Webb PM
Cancer Causes Control; 2012 Mar; 23(3):513-9. PubMed ID: 22245995
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for young premenopausal women with endometrial cancer.
Soliman PT; Oh JC; Schmeler KM; Sun CC; Slomovitz BM; Gershenson DM; Burke TW; Lu KH
Obstet Gynecol; 2005 Mar; 105(3):575-80. PubMed ID: 15738027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
